109
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

A comparison of the genetic and clinical risk factors for arterial hypertension between indigenous and non-indigenous people of the Shoria Mountain Region

, , ORCID Icon, &
Pages 324-331 | Received 22 May 2017, Accepted 02 Sep 2017, Published online: 13 Oct 2017

References

  • Bertuccio P, Levi F, Lucchini F, Chatenoud L, Bosetti C, Negri E, La Vecchia C. Coronary heart disease and cerebrovascular disease mortality in young adults: recent trends in Europe. Eur J Cardiovasc Prev Rehabil. 2011;18(4):627–34.
  • Guoheng X. Role of perilipin phosphorylation on the control of lipolysis in adipocytes. Chin J Pathophysiology. 2006;22(13):69.
  • Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension. Clin Exp Hypertens. 2001;23(6):489–500.
  • Kameda W, Daimon M, Oizumi T, Jimbu Y, Kimura M, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, et al. Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Funagata Study. Metabolism. 2005;54(5):669–76.
  • Singh M, Singh AK, Pandey P, Chandra S, Singh KA, Gambhir IS. Molecular genetics of essential hypertension. Clin Exp Hypertens. 2016;38(3):268–77.
  • Yamada Y, Matsui K, Takeuchi I, Oguri M, Fujimaki T. Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study. Int J Mol Med. 2015;35(5):1189–98.
  • Singh M, Singh AK, Singh S, Pandey P, Chandra S, Gambhir IS. Angiotensin-converting enzyme gene I/D polymorphism increases the susceptibility to hypertension and additive diseases: A study on North Indian patients. Clin Exp Hypertens. 2016;38(3):305–11.
  • Gao Y, Lin Y, Sun K, Wang Y, Chen J, Wang H, Zhou X, Fan X, Hui R. Orthostatic blood pressure dysregulation and polymorphisms of β-adrenergic receptor genes in hypertensive patients. J Clin Hypertens. 2014;16(3):207–13.
  • Yun L, Xu R, Li G, Yao Y, Li J, Cong D, Xu X, Zhang L. Homocysteine and the C677T gene polymorphism of its key metabolic enzyme MTHFR are risk factors of early renal damage in hypertension in a Chinese han population. Medicine. 2015;94(52):e2389.
  • Seidlerovа J, Filipovsky J, Mayer O, Kuсerovа A, Pesta M. Association between endothelial NO synthase polymorphisms and arterial properties in the general population. Nitric Oxide. 2015;44:47–51.
  • Cоwlеy АW. Thе gеnеtic dissеctiоn оf еssеntiаl hyреrtеnsiоn. Nаturе Rеv Gеnеtics. 2006;7(11):829–40.
  • Еichlеr ЕЕ. Missing hеritаbility аnd strаtеgiеs fоr finding thе undеrlying cаusеs оf cоmрlех disеаsе. Nаt Rеv Gеnеt. 2010;11(6):446–50.
  • Shakhtshneider EV, Yudin NS, Damba LD, Gubina MA, Maksimov VN, Barbarash OL, Ogarkov MY, Polikutina OM, Kazachek YV, Kulikov IV, et al. On the question of the ethnic characteristics of nuclear and mitochondrial gene pools Shor. The gene pool of the population of Siberia. Collection of scientific articles. Novosibirsk; 2003. С.174-176. (In Russ).
  • Fox CS, Heard-Costa NL, Vasan RS, Murabito JM, D’Agostino RB, Atwood LD. Genome wide linkage analysis of weight change in the Framingham heart study. J Clin Endocrinol Metab. 2005;5:3197–201.
  • Snapir A, Scheinin M, Groop LC, Orho-Melander M. The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes. Cardiovasc Diabetol. 2003;2:15.
  • Lima JJ, Feng H, Duckworth L, Wang J, Sylvester JE, Kissoon N, Garg H. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism. 2007;56(6):757–65.
  • Salimi S, Firoozrai M, Nourmohammadi I, Shabani M, Mohebbi A. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res. 2006;124(6):683–88.
  • Joffres M, Falaschetti E. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischemic heart disease mortality: a cross sectional study. BMJ Open. 2013;3:657–68.
  • Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10–17.
  • Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;38:2224–60.
  • Chazova IE, Zhernakova I, Oshchepkova EV, Shalnova SA, Jarovaya EB, Konradi AO, Boitsov SA. Prevalence of risk factors for cardiovascular disease in the Russian population of patients with hypertension. Cardiology. 2014;10:4–12. (In Russ.).
  • Muromtseva GA, Koncevaya AV, Konstantinov VV, Artamonova GV, Gatagonova TM, Duplyakov DV, Efanov A, Zhernakova Y, Ilyin VA, Conradi AO, et al. Prevalence of risk factors for noncommunicable diseases in the Russian population in 2012-2013. Results of the study ESSAY-RF. Cardiovascu Therapy Prev. 2014;13(6):4–11. (In Russ.).
  • Redon J, Olsen MN, Cooper RS, Zurriaga O, Martinez-Beneito MA, Laurent S, Cifkova R, Coca A, Mancia G. Stroke mortality trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011;32:1424–31.
  • Hubert HB, Fienleib M, McNamara PT, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26 year follow up of participants of the framingham heart study. Circulation. 1983;67:968–77.
  • Penesova A, Cizmarova E, Kvetnansky R, Koska J, Sedlakova B, Krizanova O. Insertion/deletion polymorphism on ACE gene is associated with endothelial dysfunction in young patients with hypertension. Horm Metab Res. 2006;8(9):592–97.
  • O’Donnel CJ, Lindpainter K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framyngham Heart Study. Circulation. 1998;97(18):1766–72.
  • Glavnik N, Petrovic D. M235T polymorphism of the angiotensinogen gene and insertion/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hypertension in Caucasians. Folia Biol (Praha). 2007;53(2):69–70.
  • Fatini C, Guazelli R, Manetti P, et al. RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study. Med Sci Sports Exerc. 2000;32(11):1868–72.
  • Zee RY, Bennett CL, Schrader AP, Morris BJ. Frequenci.es of variants of candidate genes in different age groups of hypertensives. Clin Exp Pharmacol Physiol. 1994;21(11):925–30.
  • Vasudevan R. Association of insertion/deletion polymorphism of alpha-adrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus in malaysian subjects. Int J Biol Sci. 2008;4(6):362–67.
  • Heinonen P, Koulu M, Pesonen U, Karvonen MK, Rissanen A, Laakso M, Valve R, Uusitupa M, Scheinin M. Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab. 1999;84 (7):2429–33.
  • Baldwin CT, Schwartz F, Baima J. Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens. 1999;12(9):853–57.
  • Etzel JP, Rana BK, Wen G, Parmer RJ, Schork NJ, O’Connor DT, Insel PA. Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension. 2005;45(6):1207–13.
  • Nieminen T, Lehtimki T, Laiho J. Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of Gprotein on heart rate and blood pressure during exercise test. Finnish Cardiovasc Study J Appl Physiol. 2006;100(2):507–11.
  • Borodulin VB, Shevchenko OV, Bychkov EN. The value of genetic mutations in the development of metabolic disorders in hypertensive patients. Saratov J Med Scientific Res. 2012;3(8):751–56. (In Russ.).
  • Bairova TA, Dolgich VV. Relationship polymorphism of endothelial nitric oxide synthase and hypertension in populations of Eastern Siberia. Bull East-Siberian Sci Center SB RAMS. 2007;3:64–65. (In Russ.).
  • De Miranda JA, Lacchini R, Belo VA, Lanna CM, Sertorio JT, Luizon MR, Tanus-Santos JE. The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents. J Hum Hypertens. 2015;29(2):109–14.
  • Soudani NY, Fakhoury RM, Kaissi SS, Zgheib NK. The role of genetic polymorphisms in endothelial nitric oxide synthase and beta2-adrenergic receptors with risk of hypertension in a sample of Lebanese people. Saudi Med J. 2014;35 (3):255–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.